Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies
<b>Background/Objectives</b>: Diabetes mellitus is a growing global health concern, driving the exploration of new therapies like cannabidiol (CBD), which shows potential in improving insulin sensitivity and glycemic control, though its effects on glucose metabolism remain unclear. This...
Saved in:
| Main Authors: | Elena Rafailovska, Elona Xhemaili, Zorica Naumovska, Olga Gigopulu, Biljana Miova, Ljubica Suturkova, Gjoshe Stefkov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/4/446 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carbohydrate metabolism in children after complex treatment of medulloblastoma
by: A. L. Kalinin, et al.
Published: (2022-02-01) -
Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)
by: Edward Chesney, et al.
Published: (2024-12-01) -
Harnessing animal model and computational experiments to discover antidiabetic compounds in Ficus racemosa
by: Mohammad Uzzal Hossain, et al.
Published: (2025-07-01) -
CBD for pets: navigating quality assurance, safety standards, and marketing strategies
by: Hannah Rideout, et al.
Published: (2025-01-01) -
Possible Anxiolytic Effects of Cannabidiol (CBD) Administration on Feline Responses to a Fear Response Test
by: Nobuo Masataka
Published: (2025-06-01)